Medicine, Health & Food

Medicine, Health & Food

Archive
Join as an Editor/Reviewer

DESCRIPTION OF CLINICOPATHOLOGY PATIENTS WITH INVASIVE BREAST CARCINOMA NO SPECIAL TYPE (NST) THAT HAVE NOT BEEN AND HAS NOT BEEN EXPERIENCED LYMPHOVASCULAR IN RS. H. ADAM MALIK MEDAN IN 2018

Volume: 45  ,  Issue: 1 , January    Published Date: 22 January 2020
Publisher Name: IJRP
Views: 750  ,  Download: 448

Authors

# Author Name
1 Hengky Ardian
2 Joko S Lukito
3 Soekimin

Abstract

ABSTRACT

Background: Breast carcinoma is the most common type of cancer affecting women. Breast cancer is cancer that can metastasize to other organs such as bones, liver, lungs, and brain, most of which cause this disease can not be treated. In breast cancer, LVI has become one of the factors for disease-free survival as well as overall survival.

Objective: to know the description of clinicopathology (age, grading, tumor size, the involvement of lymph nodes, and stage) patients with breast carcinoma Invasive No special type (NST) who have and have not experienced Lymphovascular Invasion.

Material and Methods: This research is a descriptive study with a cross-sectional approach of 54 NST patients. Data on the clinicopathological characteristics were obtained from the patient's medical records. Then, a slide review is conducted. The results of the data analysis are presented in the form of a frequency table.

Results: Based on age, LVI positive breast cancer was most vulnerable at the age of 35-49 years 4 people, LVI tumor size was highest at ≤5 cm in size of 3 people, LVI positive with no involvement of 5 KGB people, at LVI positive stage most at stage II that is equal to 2 people, and the most positive grade is LVI in grade 2 which is equal to 3 people.

Conclusion: LVI is one of the prognostic factors in patients with invasive breast cancer no special type (NST) and should be reported in the diagnosis of anatomic pathology

Keywords: Invasive breast cancer no special type (NST) and Lymphovascular Invasion (LVI)

 

Keywords

  • Invasive breast cancer no special type (NST) and Lymphovascular Invasion (LVI)